Ocular Therapeutix OCUL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$88.61M-38.3% | -$64.65M-33.6% | -$69.42M-90.2% | -$67.81M-54.9% | -$64.05M+1.2% | ||
| $1.28M+30.8% | $1.25M+31.1% | $1.07M+11.5% | $1.03M+7.3% | $981K+6.6% | ||
| $15.58M+49.0% | $11.36M+57.8% | $11.69M+76.0% | $9.68M-14.3% | $10.46M+31.1% | ||
| -$65.99M-47.7% | -$54.25M-37.6% | -$50.73M-38.7% | -$55.24M-123% | -$44.67M-31.8% | ||
| $4.66M+141% | $2.84M+1,305% | $5.99M+6,634% | $1.25M+67.8% | $1.93M+658% | ||
| -$4.66M-141% | -$2.84M-1,305% | -$5.99M-6,634% | -$1.12M-50.3% | -$1.93M-658% | ||
| $294K-93.0% | $449.38M+9,857% | $10.36M+148% | $97.81M+4,354% | $4.18M-98.7% | ||
| -$70.36M-65.9% | $392.29M— | -$46.36M— | $41.45M— | -$42.42M-115% | ||
| -$70.66M-51.6% | -$57.09M-44.0% | -$56.72M-54.8% | -$56.48M-121% | -$46.6M-36.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ocular Therapeutix generate?
- Ocular Therapeutix (OCUL) generated -$226.2M in operating cash flow over the trailing twelve months.
- What is Ocular Therapeutix's free cash flow?
- After $14.7M of capital expenditures, Ocular Therapeutix's free cash flow was -$240.9M over the trailing twelve months, down 62.3% year over year.
- Where does Ocular Therapeutix's cash flow data come from?
- Every line is extracted from Ocular Therapeutix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
